1. Table of Contents
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Prostatic Intraepithelial Neoplasia Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Prostatic Intraepithelial Neoplasia Clinical Trials by Region
2.2.2 Average Enrollment of Prostatic Intraepithelial Neoplasia Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Prostatic Intraepithelial Neoplasia Treatment, 2019

3. Region wise Prostatic Intraepithelial Neoplasia Clinical Trials
3.1 Asia Pacific Prostatic Intraepithelial Neoplasia Clinical Trials by Country
3.2 Europe Prostatic Intraepithelial Neoplasia Clinical Trials by Country
3.3 North America Prostatic Intraepithelial Neoplasia Clinical Trials by Country
3.4 Middle East and Africa Prostatic Intraepithelial Neoplasia Clinical Trials by Country
3.5 South and Central America Prostatic Intraepithelial Neoplasia Clinical Trials by Country

4. Prostatic Intraepithelial Neoplasia Clinical Trial Trends
4.1 Start Year wise Prostatic Intraepithelial Neoplasia Clinical Trials
4.2 Phase wise Prostatic Intraepithelial Neoplasia Clinical Trials
4.3 Trial Status wise Prostatic Intraepithelial Neoplasia Clinical Trials
4.4 Trial Type wise Prostatic Intraepithelial Neoplasia Clinical Trials

5. Prostatic Intraepithelial Neoplasia Average Enrollment Trends
5.1 Average Enrollment in Prostatic Intraepithelial Neoplasia Trials by Year
5.2 Average Enrollment in Prostatic Intraepithelial Neoplasia Trials by Phase
5.3 Average Enrollment in Prostatic Intraepithelial Neoplasia Trials by Status
5.4 Average Enrollment in Prostatic Intraepithelial Neoplasia Trials by Type of Trial

6. Companies Participating in Prostatic Intraepithelial Neoplasia Clinical Trials
6.1 Prostatic Intraepithelial Neoplasia Trials by Sponsor Type
6.2 Prostatic Intraepithelial Neoplasia Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Prostatic Intraepithelial Neoplasia Trials- Phase 1
7.2 Prostatic Intraepithelial Neoplasia Trials- Phase 2
7.3 Prostatic Intraepithelial Neoplasia Trials- Phase 3
7.4 Prostatic Intraepithelial Neoplasia Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Prostatic Intraepithelial Neoplasia Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Prostatic Intraepithelial Neoplasia Clinical Trials and Enrolment
Figure 5: Europe – Country wise Prostatic Intraepithelial Neoplasia Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Prostatic Intraepithelial Neoplasia Clinical Trials and Enrolment
Figure 7: North America – Country wise Prostatic Intraepithelial Neoplasia Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Prostatic Intraepithelial Neoplasia Clinical Trials and Enrolment
Figure 9: Prostatic Intraepithelial Neoplasia Clinical Trials by Phase
Figure 10: Prostatic Intraepithelial Neoplasia Clinical Trials by Trial Status
Figure 11: Prostatic Intraepithelial Neoplasia Clinical Trials by Type
Figure 12: Prostatic Intraepithelial Neoplasia Clinical Trials by Sponsor Type
Figure 13: Prostatic Intraepithelial Neoplasia Clinical Trials by Leading Sponsors
Figure 14: Prostatic Intraepithelial Neoplasia Average Enrollment by Phase
Figure 15: Prostatic Intraepithelial Neoplasia Average Enrollment by Trial Status
Figure 16: Prostatic Intraepithelial Neoplasia Average Enrollment by Type
Figure 17: Prostatic Intraepithelial Neoplasia- Average Enrolment by Type of Sponsors
Figure 18: Prostatic Intraepithelial Neoplasia- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

List of Tables
Table 1: Prostatic Intraepithelial Neoplasia Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Prostatic Intraepithelial Neoplasia Clinical Trials and Enrolment
Table 5: Europe – Country wise Prostatic Intraepithelial Neoplasia Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Prostatic Intraepithelial Neoplasia Clinical Trials and Enrolment
Table 7: North America – Country wise Prostatic Intraepithelial Neoplasia Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Prostatic Intraepithelial Neoplasia Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Prostatic Intraepithelial Neoplasia Average Enrollment by Phase
Table 15: Prostatic Intraepithelial Neoplasia Average Enrollment by Trial Status
Table 16: Prostatic Intraepithelial Neoplasia Average Enrollment by Type
Table 17: Prostatic Intraepithelial Neoplasia- Average Enrolment by Type of Sponsors
Table 18: Prostatic Intraepithelial Neoplasia- Enrolment by Leading Sponsors

Companies mentioned
Advanced Clinical LLC, GTx Inc, Ilmix Group, SOFAR SpA